Samuel Singer

Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.

D. Neuberg, M. Mihm, F. Hodi, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

D. Neuberg, M. Mihm, A. Berns, 1998, Proceedings of the National Academy of Sciences of the United States of America.

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

M. Mihm, G. Dranoff, A. Sober, 1997, Human gene therapy.

Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition

P. Hegde, R. Strowd, E. Severson, 2022, The oncologist.